glp 1 journal GLP-1 The promise of #GLP-1 receptor

Hanmi Pharmaceutical is accelerating its global expansion around efpeglenatide, Koreas first independently developed GLP-1class treatment for obesity and metabolic diseases

The vitreous, the jelly-like substance inside the eyes, can shrink and become more liquid with age

Patients with conditions that impair gastrointestinal absorption or require rapid drug delivery, such as sepsis or trauma, may also benefit from IV therapy at our practice

[DOI] [PubMed] [Google Scholar] Jin W, 2020

77 found that ferroptosis was functionally relevant in vivo in acute tubular necrosis and ischemia/reperfusion (I/R) injury and showed that a ferroptosis inhibitor, a new third-generation ferrostatin (termed 1686), protected against this injury